Cargando…
Precision Medicine for Colorectal Cancer with Liquid Biopsy and Immunotherapy
SIMPLE SUMMARY: There are some challenges to improve the clinical outcome of colorectal cancers (CRCs) by implementing new technologies, such as early detection of recurrence/relapse and selection of appropriate drugs based on the genomic profiles of tumors. For example, the genomic characteristics...
Autores principales: | Nagayama, Satoshi, Low, Siew-Kee, Kiyotani, Kazuma, Nakamura, Yusuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507967/ https://www.ncbi.nlm.nih.gov/pubmed/34638288 http://dx.doi.org/10.3390/cancers13194803 |
Ejemplares similares
-
Personalized immunotherapy in cancer precision medicine
por: Kiyotani, Kazuma, et al.
Publicado: (2021) -
Clinical significance of clonal hematopoiesis in the interpretation of blood liquid biopsy
por: Chan, Hiu Ting, et al.
Publicado: (2020) -
Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet?
por: Mirza, Sheefa, et al.
Publicado: (2023) -
Breast cancer: The translation of big genomic data to cancer precision medicine
por: Low, Siew‐Kee, et al.
Publicado: (2017) -
Clonal Hematopoiesis in Liquid Biopsy: From Biological Noise to Valuable Clinical Implications
por: Chan, Hiu Ting, et al.
Publicado: (2020)